Related Experiment Video
Updated: Aug 17, 2026
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
NOD2 mutation and mice: no Crohn's disease but many lessons to learn
1University of California-Davis School of Medicine, Department of Microbiology and Immunology, 1 Shield Avenue, Tupper Hall 3146, Davis, CA 95616, USA. jwehkamp@ucdavis.edu
Abstract:
Many patients with ileal Crohn's disease, a chronic intestinal inflammation, carry mutations in the gene encoding NOD2 (CARD15), but the mechanistic details of how this mutation leads to disease are not fully understood. NOD2 is expressed in antigen-presenting cells and Paneth cells, which are secretory epithelial cells of the small intestine. Two complementary studies using genetically engineered murine models help to explain the association of NOD2 malfunction and mucosal disease. One study observes a dysregulation of proinflammatory responses, suggesting that the most common NOD2 mutation in humans results in a gain of function. The other study determined that NOD2-null mutations impair the Paneth-cell antimicrobial response, which is consistent with recent findings in humans. Together, these studies fuel optimism that new therapeutic directions might emerge to better treat this severe mucosal disease.
Insights
Mutations in NOD2 (CARD15) are linked to Crohn's disease. Studies in mice reveal NOD2 malfunction causes both increased inflammation and impaired Paneth cell antimicrobial function, offering new therapeutic targets.
Area of Science:
- Immunology
- Gastroenterology
- Genetics
Background:
- Crohn's disease is a chronic intestinal inflammation.
- Mutations in the NOD2 (CARD15) gene are common in patients with ileal Crohn's disease.
- The precise mechanisms linking NOD2 mutations to Crohn's disease pathogenesis remain unclear.
Purpose of the Study:
- To elucidate the mechanistic details of how NOD2 (CARD15) gene mutations contribute to ileal Crohn's disease.
- To investigate the role of NOD2 in immune responses within the small intestine.
Main Methods:
- Utilized genetically engineered murine models to study NOD2 function.
- Analyzed proinflammatory responses in NOD2-mutated models.
- Assessed Paneth cell antimicrobial function in NOD2-null models.
Main Results:
- One study indicated that the most common human NOD2 mutation leads to a gain of function, causing dysregulation of proinflammatory responses.
- Another study found that NOD2-null mutations impair the Paneth cell antimicrobial response, aligning with human findings.
- These findings collectively explain the association between NOD2 malfunction and mucosal disease.
Conclusions:
- NOD2 (CARD15) plays a critical role in maintaining intestinal homeostasis.
- Dysfunctional NOD2 contributes to Crohn's disease through both aberrant inflammatory signaling and compromised host defense.
- These insights may pave the way for novel therapeutic strategies for Crohn's disease.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...